<DOC>
	<DOCNO>NCT02505399</DOCNO>
	<brief_summary>Rotational atherectomy ( RA ) prior angioplasty reference treatment highly calcify atherosclerotic coronary lesion . It aim fragment calcium deposit microscopic particulate allow less hazardous coronary revascularization stenting . The main drawback associate procedure subsequent enhancement platelet aggregation promote distal embolization micro-thrombi atherosclerotic fragment . In order limit complication , double antiplatelet therapy require ( generally Clopidogrel + Aspirin ) RA procedure perform . Clopidogrel inhibit protein P2Y12 cornerstone platelet aggregation . Ticagrelor new antiplatelet agent provide faster great P2Y12 inhibition Clopidogrel . It currently indicate reduce risk cardiovascular event patient hospitalize coronary revascularization acute coronary syndrome . Ticagrelor never evaluate far stable coronary patient treat rotational atherectomy prior angioplasty .</brief_summary>
	<brief_title>TIcagrelor Rotational Atherectomy Reduce TROPonin Enhancement : TIRATROP Study</brief_title>
	<detailed_description>Rotational atherectomy ( RA ) prior angioplasty reference treatment highly calcify atherosclerotic coronary lesion . It aim fragment calcium deposit microscopic particulate allow less hazardous coronary revascularization stenting . The main drawback associate procedure subsequent enhancement platelet aggregation promote distal embolization micro-thrombi atherosclerotic fragment . In order limit complication , double antiplatelet therapy require ( generally Clopidogrel + Aspirin ) RA procedure perform . Clopidogrel inhibit protein P2Y12 cornerstone platelet aggregation . It characterize slow variable transformation prodrug active metabolite remain risk thrombosis myocardial infarction . Ticagrelor new antiplatelet agent provide faster great P2Y12 inhibition Clopidogrel . It currently indicate reduce risk cardiovascular event patient hospitalize coronary revascularization acute coronary syndrome . Ticagrelor never evaluate far stable coronary patient treat rotational atherectomy prior angioplasty .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Inclusion criterion : Stable coronary patient , patient present non STelevation acute coronary syndrome without troponin elevation , troponin back normal , Patient treat combination Aspirin + Clopidogrel hospitalization study center , Patient least one highly calcified coronary lesion eligible rotational atherectomy prior angioplasty , Patient agree participate full information study . Exclusion criterion : Acute coronary syndrome STelevation , Plasma troponin level high 3 time upper limit laboratory , Lesion locate coronary bypass , Coronary thrombus diagnose angiography , Coronary dissection diagnose angiography , Left ventricular ejection fraction lower 30 % , Contraindication use Ticagrelor Clopidogrel list Summary Product Characteristics ( SmPC , annex 1 &amp; 2 ) : Known hypersensitivity active substance excipients , Active pathological bleeding , History intracranial hemorrhage , Moderate severe hepatic impairment , Coadministration strong cytochrome P450 3A4 inhibitor ( e.g . ketoconazole , clarithromycin , nefazodone , ritonavir , atazanavir ) , Other condition increase risk bleeding : Congenital acquire coagulation disorder Gastroduodenal bleeding within past 6 month , Recent major trauma surgery within past 30 day , Concomitant use fibrinolytics , oral anticoagulation , nonsteroidal antiinflammatory drug , Significant anemia , Increased risk bradycardia , History asthma Chronic Obstructive Pulmonary Disease , Uric acid nephropathy , Ischemic stroke within 7 day , Heredity galactose intolerance , Lapp lactase deficiency , glucosegalactose malabsorption , Concomitant use strong CYP3A4 inducer Concomitant use CYP3A4 substrates narrow therapeutic index ( e.g . cisapride , ergot alkaloid ) , simvastatin dose great 40 mg/d , Concomitant use Selective Serotonin Reuptake inhibitor , Concomitant use digoxin without close clinical laboratory monitoring , Contraindication use Aspirin , Breastfeeding , Pregnancy , Adult protect law , Patient participate another biomedical research .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Rotational Atherectomy</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>thrombosis</keyword>
	<keyword>ticagrelor</keyword>
</DOC>